Clinical experience indicates that limited or no reverse left ventricular (LV) remodelling may not necessarily imply non-response to cardiac resynchronization therapy (CRT). We investigated the association of the extent of LV remodelling, mechanical dyssynchrony, and survival in patients undergoing CRT. 
Introduction
Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in chronic heart failure (HF) patients with severe left ventricular (LV) systolic dysfunction and widened QRS who remain symptomatic despite optimal medical treatment.
1,2 However, depending on the definition of response, about 30-45% of patients fail to respond to this therapy. 3, 4 Left ventricular reverse remodelling, i.e.
reduction in end-systolic volume (ESV) of > _10-15% during a shortterm follow-up, has been suggested to be predictive for the improvement in clinical outcome and has been the most commonly used echocardiographic surrogate criterion of response to CRT in studies with short-term follow-up. [5] [6] [7] However, the absence of substantial LV reverse remodelling may not in all cases be equal to a failure of CRT. One may hypothesize, that a mild reverse remodelling or even an unchanged LV volume status may be still better than further volume expansion and functional deterioration. In addition, a significant proportion of initial short-term non-responders may slowly improve and experience an echocardiographic response after a longer period of time. 8, 9 Therefore, the current practice of classifying CRT patients into responders and non-responders based on an early assessed volumetric response of a certain magnitude may not be fully justified or even misleading. 10 We hypothesize that volumetric response to CRT should be regarded as a continuous spectrum ranging from cessation of volume increase to LV reverse remodelling, rather than reaching a prespecified LV volume reduction. In this retrospective analysis of the PREDICT-CRT study, we therefore investigated the association of volumetric response assessed 1 year after device implantation with long-term survival and compared it with the successful correction of specific mechanical dyssynchrony patterns, such as apical rocking (ApRock) and/or septal flash (SF), which have previously been shown to be associated with LV reverse remodelling and improved survival after CRT implantation as well. [11] [12] [13] [14] [15] [16] [17] Methods A total of 356 CRT candidates (mean age 64 ± 10 years, 73% male) from seven European centres was included in this sub-analysis of the PREDICT-CRT study. 11 The inclusion criteria were LV ejection fraction (LVEF) of < _35%, QRS width > _120 ms, NYHA functional class II-IV, and optimal medical therapy at least 3 months before CRT. There was no central blind reading of electrocardiograms and the diagnosis of left bundle branch block was made using conventional criteria, including QRS duration > 120 ms, QS or rS in lead V1, monophasic R wave with no Q wave in lead V6 and I. Ischaemic aetiology of heart failure was proven by coronary angiography or by a documented history of myocardial infarction, but none of the patients with ischaemic cardiomyopathy had symptoms of angina or required revascularization for symptomatic coronary artery disease. To be included in this sub-study, all patients had to have a baseline and a 12 ± 3 months follow-up echocardiographic study for the assessment of volumetric response. For the assessment of the association of long-term survival and volumetric response, the time of the follow-up echo examination was used as starting point for the observation. Data on all-cause mortality were collected from clinical records, by interview with the patients' general practitioner or close relatives, and/or from national death registries. The study was approved by the Ethics Committee of the University of Leuven.
Echocardiographic data
Standard echocardiographic data were acquired using commercially available scanners (Vivid 5, 7, and E9, GE Vingmed Ultrasound, Horton, Norway) and analysed off-line using EchoPac workstations. Baseline and follow-up data of one patient were analysed separately by a physician blinded to any other patient data, including the results of the respective other echo examination. LV volumes and ejection fraction were calculated using the modified biplane Simpson method. Depending on the extent of LV ESV change from baseline to follow-up assessment and considering the normal variability of echocardiographic biplane LVESV measurements, patients were divided into four arbitrary subgroups: 'no LV remodelling', defined as ESV change in the range of 0 ± -5%; 'mild LV reverse remodelling', defined as ESV reduction of >5 and <15%; 'significant LV reverse remodelling', defined as ESV reduction of > _15%; and 'LV volume expansion', defined as ESV expansion of > _5%.
Assessment of mechanical dyssynchrony
Mechanical dyssynchrony was defined as the presence of ApRock or SF on conventional 2D echocardiographic images. ApRock and SF were assessed visually pre-and post-CRT implantation, at the same time points and from the same image loops as volumetric response. Visual assessment of mechanical dyssynchrony has been described earlier. 11, 18 In brief,
ApRock was considered present if a short-lived early systolic septal motion of the apex and a predominantly lateral motion during ejection were seen in at least one apical view. Any other time course of apex motion was not regarded as ApRock. Septal flash was defined as an early (within QRS width), rapid short septal inward motion seen in apical four-chamber, parasternal long-axis or parasternal short-axis view. Mechanical dyssynchrony was considered corrected if there were neither ApRock nor SF visible on follow-up echocardiographic images. Six blinded readers from three of the participating centres with 3-10 years of experience in echocardiography were involved. All readings were initially performed by two readers. To reach a majority decision in case of disagreement, the readings of a blinded third reader were used.
Cardiac resynchronization therapy
All patients received a biventricular pacemaker. LV pacing leads were positioned, guided by coronary venography, into the lateral or posterolateral cardiac vein whenever possible. Device programming and subsequent optimization were left to the discretion of the implanting physician. In general, initial programming was aimed at obtaining the narrowest QRS width, while device settings were optimized during follow-up based, as deemed clinically appropriate, on surface ECG and Doppler echocardiography.
Statistical analysis
Continuous data are expressed as mean ± standard deviation. Normally distributed data were compared between groups using unpaired t-test and analysis of variance for continuous variables and Fisher's exact test for categorical variables. In case of serious deviation from normal distribution, median and interquartile range (IQR) and a Wilcoxon rank sum test were used. Survival rates were assessed using Kaplan-Meier methodology, while differences in survival were compared between groups by a log-rank test. Univariable and multivariable predictors of long-term survival were analysed in Cox's proportional hazards model. The multivariable regression models included variables with univariable P-values <0.10.
In order to identify a potential 'optimal' cut-off for the percentage change in ESV, we used Akaike's information criterion (AIC). 19 AIC is a goodness-of-fit criterion whereby lower values indicate a better fit of the model to the data. For every possible cut-off of the percentage change in ESV, a Cox regression was performed using the dichotomized percentage change as the only factor in the model. The optimal cut-off was the cut-off value for which the resulting AIC value was the lowest. Because the resulting 'optimal' cut-off is susceptible to small changes in the data, 500 bootstrap samples were taken from our study cohort and the above analysis was repeated on each, hence obtaining 500 'optimal' cut-offs. The accuracy of the percentage change in ESV and ApRock for the prediction of overall mortality was assessed by calculating the integrated Brier scores. 20 All statistical tests were two-tailed, and a P-value <0.05 was considered significant. Statistical analysis was performed using commercially available software (PASW Statistics, version 18, SPSS, Inc., Chicago, IL, USA) and SAS for Windows (version 9.4, SAS institute, Cary, NC, USA).
Results
The main results of the PREDICT-CRT study have been published earlier. 11 From the total PREDICT-CRT study population 50 patients died too early to be included, 552 patients had their follow-up echo examination outside the permitted window, while 458 patients had volumetric response assessed within 12 ± 3 months of CRT implantation. From these 458 patients, 102 had to be excluded from the analysis due to incomplete echocardiographic examinations or insufficient image quality for reliable LVESV measurements. Of note, despite some differences in baseline characteristics (Supplementary data online, NYHA class IV, n (%) 10 (17) 5 (14) 7 (14) 20 (10) survival (log rank P = 0.307, Supplementary data online, Figure S1 ) between the included and excluded patients.
The baseline clinical and echocardiographic characteristics of our patient population are summarized in Table 1 . Of 356 included patients, 59 (17%) showed volume expansion and 37 (10%) no volume change while 51 (14%) patients had moderate and 209 (59%) significant LV reverse remodelling at 1-year (12 ± 3 months) follow-up. Characteristics of the four patient groups are shown in Table 2 . Patients with significant LV reverse remodelling were more frequently female, had more often LBBB, non-ischaemic cardiomyopathy and a lower baseline LVEF than patients from other groups ( Table 2) . Changes in mechanical dyssynchrony and LV volumes after CRT in a typical responder and non-responders are shown in Figure 1 . LV volume expansion despite CRT (17% of the study population) had a worse overall mortality than patients from all other groups, including those with no LV remodelling (P = 0.021) and mild reverse remodelling (P = 0.009) (Figure 2) . The change of LVESV during follow-up was also tested as a continuous variable ( Table 3) . In a univariable analysis, every 10% decrease in LVESV was associated with a 14% reduction in all-cause mortality (P < 0.001). After adjusting for all other significant covariates, LVESV change remained independently associated with survival, with a 8% reduction in mortality for every 10% decrease in LVESV (P = 0.005). Corrected mechanical dyssynchrony, baseline NYHA class and age were other variables independently associated with long-term survival, with the strongest association observed for corrected mechanical dyssynchrony.
Extent of LVESV changes and survival
Optimal cut-off of LVESV changes for predicting survival after CRT Kaplan-Meier curves with corresponding v 2 values for the predefined cut-off points of LVESV change during follow-up are shown in Figure 3 . All tested partition values resulted in a significant separation of the survival curves (log lank P < 0.001 for all). The AIC values for each assessed cut-off for the first 100 bootstrap samples are shown in Figure 4 . The AIC values were lowest for decreases of LV ESV between -40 and 0%. Integrated Brier scores showed that correction of mechanical dyssynchrony was more strongly associated with patient outcome than the percentage change in ESV (Supplementary data online, Table S2 ).
Dyssynchrony and survival
Mechanical dyssynchrony, corrected by CRT, was associated with a 71% reduction in long-term mortality (P < 0.0001). Table 2 shows the distribution of mechanical dyssynchrony and its correction in the four patients groups. The majority of patients with significant LV reverse remodelling (87%) had mechanical dyssynchrony which had been corrected by CRT. Seven of 10 patients with further LV volume expansion despite corrected mechanical dyssynchrony had an ischaemic origin of cardiomyopathy. Most patients with further adverse LV remodelling after CRT had no (64%) or uncorrected mechanical dyssynchrony (18%).
Discussion
Our study data show that LV ESV change, assessed at 1-year after CRT, is independently associated with long-term survival of the CRT recipient. Although a significant reverse remodelling was associated with the best survival, each of the tested volumetric partition values for the changes in ESV separated two groups of patients which differed significantly with respect to their survival. However, we could not establish an 'optimal' volumetric cut-off which separated best. Correction of mechanical dyssynchrony after CRT was strongly associated with long-term survival and differentiated better patients with better and worse outcome than any of the tested volumetric partition values.
Reverse remodelling and survival
The relationship between LV reverse remodelling and improved long-term survival in patients with systolic HF has been observed long before the advent of CRT. The ability of beta-blockers and ACE inhibitors to induce LV reverse remodelling and improve survival was validated in landmark trials before they became a cornerstone treatment for systolic HF. 21, 22 When the ability of CRT devices to induce LV reverse remodelling became apparent, a reduction in LV endsystolic volume during follow-up has started to be used in CRT trials as surrogate endpoint. Based on data from small, observational studies, reductions of 10-15% in LV end-systolic volume at 3-6 months after device implantation emerged as a widely accepted definition of volumetric response to CRT, [3] [4] [5] [6] [7] 11, 23, 24 although a myriad of response definitions with poor agreement has also been proposed. 25 Our data do not support this volumetric response paradigm. Our data rather suggest that a stabilization of LV size as well as mild LV reverse remodelling can also be a sign of a positive treatment effect as we found for each volumetric partition value a group of patients with less favourable long-term outcome when this was not reached. An individual patient without reverse remodelling might therefore be in some cases a responder, as he would have done worse without CRT, while in another patient the same volumetric response could be an indication of therapy failure. An established statistical approach (AIC) was used to validate the surrogate parameter LV ESV change based on the long-term survival of the patients. Surprisingly, a wide range of cut-off-values between 0 and -40% appeared to perform equally good (Figure 4) . We therefore conclude, that volumetric response is a sign of favourable outcome, but its binary use as surrogate parameter for therapy success is not justified.
Our inferences on the relationship of LV volume changes and mortality after CRT concur with those of Solomon et al., 7 Doltra et al., 26 and Gold et al. 27 who also pointed at the difficulty of classifying volumetric response to CRT as a dichotomous variable. The concept of 'dichotomous' volumetric response must also be questioned because of a potentially delayed echocardiographic response to CRT. A significant portion of volumetric non-responders (45%) after 1 year of CRT experience a delayed response after a longer period of time with survival rates similar to other responders, regardless of the time at which the response occurred. 8 
Corrected dyssynchrony and survival
Patients with corrected mechanical dyssynchrony showed 71% reduction in all-cause mortality. It has recently been shown that this effect could be ascribed to the improvement of LV longitudinal and circumferential function, but also to the decrease in mechanical dispersion which has been linked to ventricular arrhythmia. 28 The prevalence of corrected mechanical dyssynchrony was significantly higher in patients with significant LV reverse remodelling (87%) compared with patients belonging to all other groups (18-30%). Of note, there were patients with no mechanical dyssynchrony showing significant LV reverse remodelling (7%) and also patients with corrected mechanical dyssynchrony and no significant LV reverse remodelling (6%). In the case of the former, it has been shown that a low-dose dobutamine challenge might help to unmask mechanical dyssynchrony in such cases. 29 Several explanations may apply to patients without LV reverse remodelling despite correction of mechanical dyssynchrony. A significant proportion of them might have been 'slow responders' and could have exhibited significant LV reverse remodelling had they been assessed after a longer period of time. 8 In addition, other approaches to analyse mechanical dyssynchrony and other factors known to influence the outcome in CRT candidates, such as discordant LV lead position and myocardial scar in the region of the LV pacing lead, were not part of the present study but might have provided the explanation for the absence of significant LV remodelling in patients with mechanical dyssynchrony. 24, 30 In our study, 17% of patients belonging to a high-risk cohort with further volume expansion despite CRT had either no or uncorrected mechanical dyssynchrony and ischaemic origin of HF. In the absence of a control group, it remains unclear whether this further adverse remodelling merely represents a lack of efficacy of CRT or a direct harmful effect.
Dyssynchrony vs. LV remodelling as predictor of survival
In our study, the association between corrected dyssynchrony and survival was higher than with any volumetric partition value. Our data therefore suggest, that the correction of specific mechanical dyssynchrony patterns is a better indicator of therapy response than LV volume reduction. This is of particular clinical interest, since the successful correction of mechanical dyssynchrony can be assessed directly after CRT implantation which provides an early feedback on the therapy success which can trigger immediate interventions in cases where a non-response can be explained by hardware problems or suboptimal settings.
Limitations
Our study is based on retrospective data from a large data base with long follow-up. Ideally, the relationship of volumetric changes, mechanical dyssynchrony and survival after CRT should be investigated in a prospective, longitudinal study with serial assessments of LVESV and mechanical dyssynchrony. Further, the comparably moderate number of finally included patients in this analysis is due to our wish Volumetric response and survival after CRT to have a well-defined follow-up time of 1 year. A preliminary analysis on the entire data base, however, led to comparable results (Supplementary data online, Figure S2 ).
Clinical implications
Our data support the notion that the higher the extent of reverse remodelling, the greater the benefit from CRT but does not support using volumetric response in clinical decision-making or as an endpoint in CRT trials. On the other hand, patients without mechanical dyssynchrony in the current study were less likely to be volumetric responders and, therefore, they should be followed for the detection of volume expansion after CRT. This subgroup of patients had the worst long-term survival and other therapeutic options, including heart transplantation, may be considered without unnecessary delay.
Conclusions
Changes in LVESV assessed at 1 year after CRT are associated with long-term all-cause mortality, but an 'optimal' cut-off point cannot be established. Left ventricular volume expansion after CRT is associated with the worst overall survival. Correction of mechanical dyssynchrony after CRT shows a stronger association with survival than 1-year LV reverse remodelling.
Supplementary Data
Supplementary data are available at European Heart Journal -Cardiovascular Imaging online.
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